Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs
Provided By GlobeNewswire
Last update: Nov 12, 2024
-- VAX-31 Infant Indication: Investigational New Drug Application Cleared by FDA; Company Expects to Initiate VAX-31 Infant Phase 2 Study by the End of January 2025 --
